Education
About Us
Working with TipRanks
Follow Us
Pfizer (PFE)
NYSE:PFE
Pf-07985631
Healthy
Phase I
Not Yet Recruiting
A Study to Learn How Different Amounts of the Study Medicine Called PF-07985631 Are Tolerated and Act in the Body in Healthy Adults
Nov 14, 2025
―
Midazolam, Pf-08049820, Dabigatran Etexilate, Portia (Ee And Ln) Or Equivalent Oral Tablet
Atopic Dermatitis
Phase I
Recruiting
A Study to Learn If the Study Medicine Called PF-08049820 Changes How the Body Processes the Other Study Medicines Called Oral Contraceptives, Midazolam, and Dabigatran in Healthy Adult Female Participants
Sep 02, 2025
Pf-08049820 Mr1, Pf-08049820 Mr2, Pf-08049820 Ir
Atopic Dermatitis
Phase I
Active Not Recruiting
A Study to Learn How Different Forms of the Study Medicine Called PF 08049820 Are Taken up Into the Bloodstream in Healthy Adults
Aug 28, 2025
―
Pf-08046054, Docetaxel Monotherapy
Non-small Cell Lung Carcinoma, Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Carcinoma
Phase III
Recruiting
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Aug 20, 2025
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Pfizer (PFE) have in its pipeline
PFE is currently developing the following drugs: Pf-07985631, Ritlecitinib 100 Mg, Ritlecitinib 50 Mg, Pf-08049820. These drug candidates are in various stages of clinical development as the company works toward FDA approval.